Hirano T, Hirohashi S, Kunii T, Noguchi M, Shimosato Y, Hayata Y
Pathology Division, National Cancer Center Research Institute, Tokyo.
Jpn J Cancer Res. 1989 Apr;80(4):348-55. doi: 10.1111/j.1349-7006.1989.tb02318.x.
Three monoclonal antibodies (mAbs), NCC-LU-243, -244 and -246, detected three different epitopes on a 145-kDa cell membrane antigen, which had been designated as the cluster 1 antigen at the First International Workshop on Small Cell Lung Cancer (SCLC) Antigens. The distribution of the antigen in various tissues, cultured cells and sera was examined by immunohistochemistry and sandwich radioimmunoassay using these mAbs. The antigen is a normal differentiation antigen and is present in neuronal, neuroendocrine and cardiac muscle cells. The level of the antigen was highest in central nervous tissues, while it was undetectable in the liver, kidney and peripheral lung. Among tumor tissues, the antigen was detected only in SCLC, carcinoid tumor and neuroblastoma, indicating its usefulness as a marker for discriminating SCLC from non-SCLC. The level of the antigen varied among SCLC tissues and tended to be lower in variant-type cultured SCLC cells. Although an increase in the antigen level was observed in sera of some patients with advanced SCLC, the antigen did not possess any additional value over neuron-specific enolase as a serum tumor marker for monitoring SCLC patients.
三种单克隆抗体(mAb),即NCC-LU-243、-244和-246,在一种145 kDa的细胞膜抗原上检测到三种不同的表位,该抗原在第一届小细胞肺癌(SCLC)抗原国际研讨会上被指定为簇1抗原。使用这些单克隆抗体,通过免疫组织化学和夹心放射免疫测定法检测了该抗原在各种组织、培养细胞和血清中的分布。该抗原是一种正常分化抗原,存在于神经元、神经内分泌和心肌细胞中。该抗原在中枢神经组织中的水平最高,而在肝脏、肾脏和外周肺中未检测到。在肿瘤组织中,该抗原仅在小细胞肺癌、类癌肿瘤和神经母细胞瘤中被检测到,表明其作为区分小细胞肺癌与非小细胞肺癌的标志物具有实用性。小细胞肺癌组织中该抗原的水平各不相同,在变异型培养的小细胞肺癌细胞中往往较低。尽管在一些晚期小细胞肺癌患者的血清中观察到该抗原水平升高,但作为监测小细胞肺癌患者的血清肿瘤标志物,该抗原相对于神经元特异性烯醇化酶没有任何额外价值。